HCPLive Five - Dermatology Updates at RAD Conference 2025

A wide array of physicians, researchers, and industry leaders gathered in Nashville, Tennessee, to attend the 2025 Revolutionizing Atopic Dermatitis (RAD) Conference, a key meeting in the field of dermatology. Throughout the latest iteration of this yearly conference, late-breaking data that related specifically to atopic dermatitis.

These data and new sessions by dermatology leaders were all presented at RAD, providing those in the dermatology space helpful insights into management, pathophysiology, and therapeutic innovations for atopic dermatitis. As part of our on-site coverage, the HCPLive editorial team reported directly from the RAD conference floor, capturing the latest data and carrying out exclusive interviews with dermatology experts, spotlighting pivotal sessions and new findings.

This edition of the 'HCPLive Five' highlights a set of 5 standout video interviews, including conversations regarding session topics such as allergy's connection to atopic dermatitis, dose flexibility, concerns over Janus Kinase (JAK)-inhibitors, and more:

Psychosocial Burdens of Atopic Dermatitis, with Mona Shahriari, MD

Mona Shahriari, MD, FAAD, associate clinical professor of dermatology at Yale University School of Medicine and host of HCPLive podcast The Medical Sisterhood, spoke with the HCPLive team about the biggest takeaways from her conference talk titled ‘The Psychosocial Burden of [Atopic Dermatitis]’. Shahriari specifically highlighted the disconnect between what a physician may perceive and what a patient experiences.

Notes on Dose Flexibility in Adult Atopic Dermatitis, with Raj Chovatiya, MD, PhD

Raj Chovatiya, MD, PhD, clinical associate professor of medicine at Rosalind Franklin University Chicago Medical School and founder and director of the Center for Medical Dermatology and Immunology Research in Chicago, interviewed with HCPLive about the most notable takeaways from his presentation at RAD 2025 titled ‘Dose Flexibility in Adult Atopic Dermatitis.' He was asked about what dose flexibility means and how it is rising in importance in the context of atopic dermatitis management.

Addressing JAK Inhibitor Concerns in Atopic Dermatitis, with Leon H. Kircik, MD

Leon H. Kircik, MD, spoke with the HCPLive team at RAD 2025 about his session titled ‘Janus Kinase (JAK) Inhibitors in Atopic Dermatitis Management.’ Kircik, who serves as medical director for Skin Sciences, PLLC, in Louisville, Kentucky, was asked about his views on the biggest clinical advantages of JAK inhibitors in atopic dermatitis, especially compared to systemic therapies or biologics.

Precision Medicine in Today’s Atopic Dermatitis Landscape, with Peter Lio, MD

Peter Lio, MD, spoke about some of the most notable takeaways from his presentation on pediatric atopic dermatitis. He was asked by HCPLive about the possibilities of personalized or 'precision' medicine as well as other takeaways from his session. Lio, who works as a clinical assistant professor of dermatology and pediatrics at Northwestern University's Feinberg School of Medicine, also touched on his own focus on personalizing plans for caregivers of patients with atopic dermatitis.

Misconceptions About Allergy’s Connection to Atopic Dermatitis, with Anne Marie Singh, MD

Anne Marie Singh, MD, presented a talk at RAD 2025 that highlighted a variety of misconceptions related to atopic dermatitis and the skin disease's connection to food allergy. Singh, an associate professor of pediatric allergy, asthma, and immunology at the University of Wisconsin's School of Medicine, spoke with the HCPLive team about patients’ and clinicians' perceptions on triggers for their atopic dermatitis flares.